Open AccessNivolumab as the new standard of metastatic kidney cancer treatment
Author(s) -
В. Б. Матвеев
Publication year - 2017
Publication title -
onkourologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 4
eISSN - 1996-1812
pISSN - 1726-9776
DOI - 10.17650/1726-9776-2017-13-3-18-26
Subject(s) - medicine , nivolumab , kidney cancer , sunitinib , tyrosine kinase inhibitor , cancer , vascular endothelial growth factor , angiogenesis , targeted therapy , metastasis , cancer research , pi3k/akt/mtor pathway , immunotherapy , oncology , vegf receptors , signal transduction , biology , biochemistry